Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
If it passes but you know it spent a day above 30C, replacing it is the cheaper decision
#NovoNordisk #Wegovy #GLP1 #Obesity #EMA #DigitalHealth #Telehealth #PharmaSupplyChain #LastMileDelivery A meaningful obesitycare infrastructure milestone as Novo Nordisk secures EMA approval for 48hour ambient (30C) finalmile delivery of Wegovy the first GLP1 injectable in Europe with this level of coldchain flexibility
Scalp changes: Redness, scaling, itching, or pain on the scalp suggests a dermatological condition that needs specific treatment
In the phase 1/2 trial, alpelisib (a PI3K inhibitor) plus nab-paclitaxel was well tolerated and showed encouraging efficacy, especially in patients with metastatic PIK3CA -mutated HER2 breast cancer, despite that TNBC has lower efficacy than HR+/HER2 patients
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
